“Smart Molecules, Safer Patients: The Dual Promise of AI in Modern Pharmacy”

AI and Machine Learning are fundamentally reshaping pharmaceutical sciences. In drug discovery, AI accelerates target identification, designs novel molecules, predicts ADMET properties, and enables drug repurposing, cutting development time from years to months while reducing costs. In pharmacovigilance, AI enhances signal detection, extracts safety data from unstructured clinical text, predicts adverse events, and automates case processing—improving patient safety surveillance significantly.Despite challenges like data quality issues, model interpretability, regulatory uncertainty, and workforce skill gaps, the integration of AI into pharmaceutical research and safety monitoring is inevitable. The Pharmacy Council of India's 2025 curriculum revision mandating AI and Python training reflects this reality.The future lies in multidisciplinary collaboration—pharmacists, data scientists, clinicians, and regulators working together. For pharmacy students, combining domain knowledge with AI literacy is no longer optional but essential. Ultimately, the goal remains unchanged: delivering safer, more effective medicines to patients faster than ever before.

(1)Z. Ahmed, K. Mohamed, S. Zeeshan, and X. Dong, "Artificial intelligence with multi functional machine learning platform development for better healthcare and precision medicine," Database, vol. 2020, article baaa010, 2020. (2)A. Wong, J. M. Plasek, S. P. Montecalvo, and L. Zhou, "Natural language processing and its implications for the future of medication safety: a narrative review of recent advances and challenges," Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol. 38, no. 8, pp. 822-841, 2018. (3)Abagyan R, Totrov M, Kuznetsov D (1994) Icm–a new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation. J Comput Chem 15(5):488–506. (4)Ain QU, Aleksandrova A, Roessler FD, Ballester PJ (2015) Machine-learning scoring functions to improve structure-based binding affinity prediction and virtual screening. Wiley Interdisciplinary Reviews. Comput Molec Sci 5(6):405–424. (5)Xu S, Cobzaru R, Finkelstein SN, Welsch RE, Ng K, Middleton L. The foundational model aided automatic high-throughput drug screening using self-controlled cohort study. (6)Pharmacy Council of India. New B.Pharm Syllabus (PCI-2025): Integration of AI and Python Programming in Pharmaceutical Education. 2025. (7)Arctoris. Arctoris Featured in BioPharma Trend Case Study on End-to-End Drug Discovery Automation. 2026. (8)AI-driven pharmacovigilance: Enhancing adverse drug reaction detection with deep learning and NLP. MethodsX. 2025;15:103460. (9)A Review on Revolutionizing Healthcare Technologies with AI and ML Applications in Pharmaceutical Sciences. Drugs Drug Candidates. 2025;4(1):9. (10)Alsuhibani A. Enhancing Post-Marketing Pharmacovigilance: An AI-Driven System Approach for Safety Signal Detection of Adverse Drug Events: A Case Study of Glucagon-Like Peptide-1 Receptor Agonists [Dissertation]. Virginia Commonwealth University; 2025.